- Which Benefits Can Justify Risks in Research?Tessa I. van Rijssel, Ghislaine J. M. W. van Thiel, Helga Gardarsdottir, Johannes J. M. van Delden & on Behalf of the Trials@Home Consortium - forthcoming - American Journal of Bioethics:1-11.details
|
|
Clinical equipoise: Why still the gold standard for randomized clinical trials?Charlemagne Asonganyi Folefac & Hugh Desmond - 2024 - Clinical Ethics 19 (1):1-11.details
|
|
Between Minimal and Greater Than Minimal Risk: How Research Participants and Oncologists Assess Data-Sharing and the Risk of Re-identification in Genomic Research.Sebastian Schleidgen, Alma Husedzinovic, Dominik Ose, Christoph Schickhardt, Christof Kalle & Eva Winkler - 2019 - Philosophy and Technology 32 (1):39-55.details
|
|
Mission Creep or Mission Lapse? Scientific Review in Research Oversight.Margaret Waltz, Jill A. Fisher & Rebecca L. Walker - 2023 - AJOB Empirical Bioethics 14 (1):38-49.details
|
|
Ethics of HIV cure research: an unfinished agenda. [REVIEW]Jeremy Sugarman, John A. Sauceda, Brandon Brown, Parya Saberi, Mallory O. Johnson, Laney Henley, Samuel Ndukwe, Hursch Patel, Morénike Giwa Onaiwu, Danielle M. Campbell, David Palm, Orbit Clanton, David Kelly, Jan Kosmyna, Michael Louella, Laurie Sylla, Christopher Roebuck, Nora Jones, Lynda Dee, Jeff Taylor, John Kanazawa & Karine Dubé - 2021 - BMC Medical Ethics 22 (1):1-14.details
|
|
Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines.Robert Steel, Lara Buchak & Nir Eyal - 2020 - Journal of Medical Ethics 46 (12):808-812.details
|
|
Reconceptualising risk–benefit analyses: the case of HIV cure research.Robert Steel - 2020 - Journal of Medical Ethics 46 (3):212-219.details
|
|
Risk Limits in Fair Subject Selection.Robert Steel - 2020 - American Journal of Bioethics 20 (2):30-32.details
|
|
Context is Needed When Assessing Fair Subject Selection.G. Owen Schaefer - 2020 - American Journal of Bioethics 20 (2):20-22.details
|
|
Clarifying how to deploy the public interest criterion in consent waivers for health data and tissue research.G. Owen Schaefer, Graeme Laurie, Sumytra Menon, Alastair V. Campbell & Teck Chuan Voo - 2020 - BMC Medical Ethics 21 (1):1-10.details
|
|
Between Minimal and Greater Than Minimal Risk: How Research Participants and Oncologists Assess Data-Sharing and the Risk of Re-identification in Genomic Research.Sebastian Schleidgen, Alma Husedzinovic, Dominik Ose, Christoph Schickhardt, Christof von Kalle & Eva C. Winkler - 2019 - Philosophy and Technology 32 (1):39-55.details
|
|
Four Faces of Fair Subject Selection.Katherine Witte Saylor & Douglas MacKay - 2020 - American Journal of Bioethics 20 (2):5-19.details
|
|
The risk-benefit task of research ethics committees: An evaluation of current approaches and the need to incorporate decision studies methods. [REVIEW]Johannes J. M. Van Delden Rosemarie D. L. C. Bernabe, Ghislaine J. M. W. Van Thiel, Jan A. M. Raaijmakers - 2012 - BMC Medical Ethics 13 (1):6.details
|
|
Setting risk thresholds in biomedical research: lessons from the debate about minimal risk.Annette Rid - 2014 - Monash Bioethics Review 32 (1-2):63-85.details
|
|
Limits on risks for healthy volunteers in biomedical research.David B. Resnik - 2012 - Theoretical Medicine and Bioethics 33 (2):137-149.details
|
|
Examining the Social Benefits Principle in Research with Human Participants.David B. Resnik - 2018 - Health Care Analysis 26 (1):66-80.details
|
|
The Moral Permissibility of Perspective-Taking Interventions.Hannah Read & Thomas Douglas - forthcoming - Ethical Theory and Moral Practice:1-16.details
|
|
Collaborative partnership and the social value of clinical research: a qualitative secondary analysis.Sanna-Maria Nurmi, Arja Halkoaho, Mari Kangasniemi & Anna-Maija Pietilä - 2017 - BMC Medical Ethics 18 (1):57.details
|
|
What Are the Implications of Applying Equipoise in Planning Citizens Basic Income Pilots in Scotland?Gerry McCartney, Neil Craig, Fiona Myers, Wendy Hearty & Coryn Barclay - 2021 - Public Health Ethics 14 (1):109-116.details
|
|
Can significant difference in regulating medical and non-medical research be justified?David Hunter - 2014 - Monash Bioethics Review 32 (3-4):254-267.details
|
|
The effect of study type on research ethics committees’ queries in medical studies.Saara M. Happo, Arja Halkoaho, Soili M. Lehto & Tapani Keränen - 2017 - Research Ethics 13 (3-4):115-127.details
|
|
Is There an Ethical Upper Limit on Risks to Study Participants?Nir Eyal - 2020 - Public Health Ethics 13 (2):143-156.details
|
|
Spheres of Morality: The Ethical Codes of the Medical Profession.Samuel Doernberg & Robert Truog - 2023 - American Journal of Bioethics 23 (12):8-22.details
|
|
The social value of candidate HIV cures: actualism versus possibilism.Regina Brown & Nicholas Greig Evans - 2017 - Journal of Medical Ethics 43 (2):118-123.details
|
|
Can informed consent to research be adapted to risk?Danielle Bromwich & Annette Rid - 2015 - Journal of Medical Ethics 41 (7):521-528.details
|
|
An Argument for Fewer Clinical Trials.Kirstin Borgerson - 2016 - Hastings Center Report 46 (6):25-35.details
|
|
News media coverage of euthanasia: a content analysis of Dutch national newspapers. [REVIEW]Rosemarie D. L. C. Bernabe, Ghislaine J. M. W. Van Thiel, Jan A. M. Raaijmakers & Johannes J. M. Van Delden - 2013 - BMC Medical Ethics 14 (1):6-.details
|
|